Chemoinformaics analysis of 14-Hydroxygelsenicine
| Molecular Weight | 342.395 | nRot | 2 |
| Heavy Atom Molecular Weight | 320.219 | nRig | 24 |
| Exact Molecular Weight | 342.158 | nRing | 6 |
| Solubility: LogS | -3.897 | nHRing | 4 |
| Solubility: LogP | 1.89 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 51.8074 |
| nHD | 1 | BPOL | 28.1206 |
| QED | 0.883 |
| Synth | 6.375 |
| Natural Product Likeliness | 2.427 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.918 |
| Pgp-sub | 0.022 |
| HIA | 0.012 |
| CACO-2 | -4.851 |
| MDCK | 0.0000526 |
| BBB | 0.935 |
| PPB | 0.503804 |
| VDSS | 0.953 |
| FU | 0.321158 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.827 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.946 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.268 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.206 |
| CYP3a4-inh | 0.116 |
| CYP3a4-sub | 0.911 |
| CL | 7.425 |
| T12 | 0.043 |
| hERG | 0.031 |
| Ames | 0.828 |
| ROA | 0.824 |
| SkinSen | 0.052 |
| Carcinogencity | 0.897 |
| EI | 0.01 |
| Respiratory | 0.816 |
| NR-Aromatase | 0.952 |
| Antiviral | No |
| Prediction | 0.517748 |